Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 31, 2007
J Am Soc Nephrol 18: 904-912, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006030221

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006030221v1
18/3/904    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liangos, O.
Right arrow Articles by Jaber, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liangos, O.
Right arrow Articles by Jaber, B. L.

Clinical Nephrology

Urinary N-Acetyl-beta-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure

Orfeas Liangos*,{dagger}, Mary C. Perianayagam*, Vishal S. Vaidya{ddagger}, Won K. Han{ddagger}, Ron Wald§, Hocine Tighiouart||, Robert W. MacKinnon*, Lijun Li{dagger}, Vaidyanathapuram S. Balakrishnan{dagger}, Brian J.G. Pereira{dagger}, Joseph V. Bonventre{ddagger} and Bertrand L. Jaber*,{dagger}

* Division of Nephrology, Caritas St. Elizabeth’s Medical Center, {dagger} Division of Nephrology and || Biostatistics Research Center, Tufts-New England Medical Center, and {ddagger} Renal Division, Brigham and Women’s Hospital, Boston, Massachusetts; and § Division of Nephrology, St. Michael’s Hospital, Toronto, Ontario, Canada

Address correspondence to: Dr. Bertrand L. Jaber, Caritas St. Elizabeth’s Medical Center, 736 Cambridge Street, Boston, MA 02135. Phone: 617-562-7832; Fax: 617-562-7797; E-mail: bertrand.jaber{at}caritaschristi.org

Received for publication March 10, 2006. Accepted for publication December 17, 2006.

The role of urinary biomarkers of kidney injury in the prediction of adverse clinical outcomes in acute renal failure (ARF) has not been well described. The relationship between urinary N-acetyl-beta-(D)-glucosaminidase activity (NAG) and kidney injury molecule-1 (KIM-1) level and adverse clinical outcomes was evaluated prospectively in a cohort of 201 hospitalized patients with ARF. NAG was measured by spectrophotometry, and KIM-1 was measured by a microsphere-based Luminex technology. Mean Acute Physiology, Age, Chronic Health Evaluation II (APACHE II) score was 16, 43% had sepsis, 39% required dialysis, and hospital mortality was 24%. Urinary NAG and KIM-1 increased in tandem with APACHE II and Multiple Organ Failure scores. Compared with patients in the lowest quartile of NAG, the second, third, and fourth quartile groups had 3.0-fold (95% confidence interval [CI] 1.3 to 7.2), 3.7-fold (95% CI 1.6 to 8.8), and 9.1-fold (95% CI 3.7 to 22.7) higher odds, respectively, for dialysis requirement or hospital death (P < 0.001). This association persisted after adjustment for APACHE II, Multiple Organ Failure score, or the combined covariates cirrhosis, sepsis, oliguria, and mechanical ventilation. Compared with patients in the lowest quartile of KIM-1, the second, third, and fourth quartile groups had 1.4-fold (95% CI 0.6 to 3.0), 1.4-fold (95% CI 0.6 to 3.0), and 3.2-fold (95% CI 1.4 to 7.4) higher odds, respectively, for dialysis requirement or hospital death (P = 0.034). NAG or KIM-1 in combination with the covariates cirrhosis, sepsis, oliguria, and mechanical ventilation yielded an area under the receiver operator characteristic curve of 0.78 (95% CI 0.71 to 0.84) in predicting the composite outcome. Urinary markers of kidney injury such as NAG and KIM-1 can predict adverse clinical outcomes in patients with ARF.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. Devarajan
Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3737 - 3743.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
C. Hudson, J. Hudson, M. Swaminathan, A. Shaw, M. Stafford-Smith, and U. D. Patel
Emerging Concepts in Acute Kidney Injury Following Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2008; 12(4): 320 - 330.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo
Cardiorenal Syndrome
J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1527 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. J. Rees and R. Kain
Kim-1/Tim-1: from biomarker to therapeutic target?
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3394 - 3396.
[Full Text] [PDF]


Home page
CJASNHome page
I. Wu and C. R. Parikh
Screening for Kidney Diseases: Older Measures versus Novel Biomarkers
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1895 - 1901.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
T. L. Nickolas, M. J. O'Rourke, J. Yang, M. E. Sise, P. A. Canetta, N. Barasch, C. Buchen, F. Khan, K. Mori, J. Giglio, et al.
Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase-Associated Lipocalin for Diagnosing Acute Kidney Injury
Ann Intern Med, June 3, 2008; 148(11): 810 - 819.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. S. Waikar, K. D. Liu, and G. M. Chertow
Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 844 - 861.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Rosen and I. E. Stillman
Acute Tubular Necrosis Is a Syndrome of Physiologic and Pathologic Dissociation
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 871 - 875.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. Ronco, J. A. Kellum, R. Bellomo, and A. A. House
Potential Interventions in Sepsis-Related Acute Kidney Injury
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 531 - 544.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. G. Coca and C. R. Parikh
Urinary Biomarkers for Acute Kidney Injury: Perspectives on Translation
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 481 - 490.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. K. Washburn, M. Zappitelli, A. A. Arikan, L. Loftis, R. Yalavarthy, C. R. Parikh, C. L. Edelstein, and S. L. Goldstein
Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 566 - 572.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. S. Haas, P. Devarajan, C. Parikh, J. Barasch, F. J. Kleeman, H. Rabb, and R. B. Colvin
Case 31-2007: a man with abdominal pain and elevated creatinine.
N. Engl. J. Med., January 17, 2008; 358(3): 312 - 312.
[Full Text] [PDF]


Home page
Toxicol SciHome page
Y. Zhou, V. S. Vaidya, R. P. Brown, J. Zhang, B. A. Rosenzweig, K. L. Thompson, T. J. Miller, J. V. Bonventre, and P. L. Goering
Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium
Toxicol. Sci., January 1, 2008; 101(1): 159 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Z. Zhang, B. D. Humphreys, and J. V. Bonventre
Shedding of the Urinary Biomarker Kidney Injury Molecule-1 (KIM-1) Is Regulated by MAP Kinases and Juxtamembrane Region
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2704 - 2714.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP